Development and optimization of an injectable formulation of copper diethyldithiocarbamate, an active anticancer agent

Mohamed Wehbe(BC Cancer Agency), Marcel B. Bally(BC Cancer Agency)

International Journal of Nanomedicine

May 1, 2017

10.2147/ijn.s137347

Cited by 65

Related Papers

Induction of Autophagy Is an Early Response to Gefitinib and a Potential Therapeutic Target in Breast Cancer

|PLoS ONE|2013|101

QLT0267, a small molecule inhibitor targeting integrin-linked kinase (ILK), and docetaxel can combine to produce synergistic interactions linked to enhanced cytotoxicity, reductions in P-AKT levels, altered F-actin architecture and improved treatment outcomes in an orthotopic breast cancer model

|Breast Cancer Research|2009|73

Suppression of Her2/neu expression through ILK inhibition is regulated by a pathway involving TWIST and YB-1

|Oncogene|2010|49

The combination of gefitinib and RAD001 inhibits growth of HER2 overexpressing breast cancer cells and tumors irrespective of trastuzumab sensitivity

|BMC Cancer|2011|28

Combined RNAi-Mediated Suppression of Rictor and EGFR Resulted in Complete Tumor Regression in an Orthotopic Glioblastoma Tumor Model

|PLoS ONE|2013|28